Edition:
United Kingdom

Spring Bank Pharmaceuticals Inc (SBPH.OQ)

SBPH.OQ on NASDAQ Stock Exchange Capital Market

11.90USD
14 Aug 2018
Change (% chg)

$0.10 (+0.85%)
Prev Close
$11.80
Open
$12.04
Day's High
$12.25
Day's Low
$11.75
Volume
35,084
Avg. Vol
21,669
52-wk High
$18.93
52-wk Low
$10.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.287
Mar '18 0.00 -0.374
FY 2017 Dec '17 0.00 -0.113
Sep '17 0.00 -0.853
Jun '17 0.00 -0.934
Mar '17 0.00 -0.690
FY 2016 Dec '16 0.00 -0.284
Sep '16 0.00 -0.535
Jun '16 0.07 -0.621
Mar '16 0.28 -1.109
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-19 4 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 4 -0.63 -0.54 -0.75 -0.46
Quarter Ending Dec-18 4 -0.63 -0.52 -0.87 -0.49
Year Ending Dec-18 5 -1.92 -1.73 -2.29 -2.23
Year Ending Dec-19 5 -2.95 -2.28 -3.83 -2.28
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.64 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 114.98 5.75
Price to Book (MRQ) 4.93 15.51 5.47
Price to Tangible Book (MRQ) 4.93 14.52 7.04
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 33.41 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -100.00 80.50 5.64
Sales - 5 Yr. Growth Rate -- 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -50.36 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago 6.83 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 16.16 5.53 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.44 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -603.21 10.65
Operating Margin (TTM) -- -759.76 4.32
Operating Margin - 5 Yr. Avg. -- -625.13 6.06
Pre-Tax Margin (TTM) -- -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -628.46 6.49
Net Profit Margin (TTM) -- -734.98 1.48
Net Profit Margin - 5 Yr. Avg. -- -631.51 2.77
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,229,989 860,364,356
Net Income/Employee (TTM) -- 3,144,143 101,205,920
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.52 -0.16 11.13
Return on Assets - 5 Yr. Avg. -- 3.50 12.40
Return on Investment (TTM) -61.33 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.55 16.13
Return on Equity (TTM) -73.77 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.42 17.39
  1 Year 3 Year 5 Year
Sales % -62.79 -18.53 --
EPS (TTM) % -46.75 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spring Bank Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 38.66%
# of Holders: 73
Total Shares Held: 5,097,757
3 Mo. Net Change: 690,228
# New Positions: 23
# Closed Positions: 1
# Increased Positions: 33
# Reduced Positions: 4
# Net Buyers: 29
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.